Clinical Trial Update: Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study assessed safety and efficacy of donor natural killer cells given after haploidentical hematopoietic cell transplantation in patients with acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Donor natural killer cells

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED